Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Jagsonpal Pharmaceuticals

BSE: 507789|NSE: JAGSNPHARM|ISIN: INE048B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 15, 16:00
34.50
0.7 (2.07%)
VOLUME 8,547
LIVE
NSE
Dec 15, 15:58
34.40
0.55 (1.62%)
VOLUME 28,840
Announcements on JagsonpalPharma

13th-Dec-2017 10:47Source: BSE

Jagsonpal Pharmaceuticals- RECONSTITUTED AUDIT & OTHER COMMITTEE(S) MEMBERS AFTER THE DEMISE OF MR. GOVIND DEO.

Mr. Rajpal Singh Kochhar, Chairman & Managing Director informed that Board need to re-constitute the Constitution of Audit Committee & other Committee(s) and it was

Resolved that Mr. Bharat ...

12th-Dec-2017 15:13Source: NSE

Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

12th-Dec-2017 14:45Source: NSE

Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 12, 2017.Sir/Madam,• The board meeting was convened at 10.00 a.m. and due to death of m...

12th-Dec-2017 14:35Source: BSE

Jagsonpal Pharmaceuticals- STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30/09/2017

STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30/09/2017

12th-Dec-2017 14:30Source: BSE

Jagsonpal Pharmaceuticals- Outcome of Board Meeting

Sir/Madam,

The board meeting was convened at 10.00 a.m. and due to death of member of Audit Committee, the Board inducted Mrs. Jasbir Kaur, woman director as member of the Audit and other C...

4th-Dec-2017 15:46Source: BSE

Jagsonpal Pharmaceuticals-
Pursuant To Regulation 29 Read With Regulation 47 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015, We Hereby Give Notice That The Meeting Of The Board Of Directors Of The Company Is Sche


Pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby give notice that the meeting of the Board of Directors ...

16th-Oct-2017 10:51Source: BSE

Jagsonpal Pharmaceuticals- Compliance Under 40(9) Of Lodr 2015

compliance 40(9)

11th-Oct-2017 16:22Source: BSE

JagsonpalPharma- Investor Grievance Regulation 13(3)

all complaints resolved.

11th-Oct-2017 10:55Source: BSE

JagsonpalPharma- Shareholding for the Period Ended September 30, 2017

Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

10th-Oct-2017 12:12Source: BSE

JagsonpalPharma- Compliance Certificate Puusuant To Regulation 7 Of SEBI (LODR) Regulation 2015.

Please find attached herewith Compliance Certificate under regulation 7 of SEBI (LODR) Regulation 2015.

The Compliance relates from 01.04.2017 to 30.09.2017.

Thnx


R K K...

1 2 3 4 5 Next >>
Quick Links for Jagsonpal Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.